Skip to content
10-Q

Quarterly Report

Mural Oncology plc

0000950170-24-125928

← back to feed
Filed
Nov 13, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 1, 2024 17.06M sh
Current Liabilities Q3 2024 · Sep 30, 2024 $24.91M
Current Liabilities Q3 2024 · Dec 31, 2023 $29.02M
Total Liabilities Q3 2024 · Sep 30, 2024 $29.13M
Total Liabilities Q3 2024 · Dec 31, 2023 $37.93M
Current Assets Q3 2024 · Sep 30, 2024 $183.79M
Current Assets Q3 2024 · Dec 31, 2023 $277.34M
Total Assets Q3 2024 · Sep 30, 2024 $203.27M
Total Assets Q3 2024 · Dec 31, 2023 $301.75M
Rd Expense Q3 2024 · Sep 30, 2024 $27.59M
Rd Expense Q3 2024 · Sep 30, 2024 $82M
Rd Expense Q3 2024 · Sep 30, 2023 $40.35M
Rd Expense Q3 2024 · Sep 30, 2023 $123.29M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $270.85M
Shares Diluted restated Q3 2024 · Sep 30, 2023 16.69M sh
Shares Diluted restated Q3 2024 · Sep 30, 2023 16.69M sh
Capex Q3 2024 · Sep 30, 2023 $2.27M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$151.52M
Stockholders Equity Q3 2024 · Sep 30, 2023 −$6.89M
Stockholders Equity Q3 2024 · Jun 30, 2023 −$10.23M
Stockholders Equity Q3 2024 · Mar 31, 2023 −$9.24M
Stockholders Equity Q3 2024 · Dec 31, 2022 −$21.66M
Eps Diluted Q3 2024 · Sep 30, 2023 −$3.07
Eps Diluted Q3 2024 · Sep 30, 2023 −$8.86
Eps Basic Q3 2024 · Sep 30, 2023 −$3.07
Eps Basic Q3 2024 · Sep 30, 2023 −$8.86
Sga Expense Q3 2024 · Sep 30, 2023 $5.96M
Sga Expense Q3 2024 · Sep 30, 2023 $14.44M
Net Income Q3 2024 · Sep 30, 2023 −$51.28M
Net Income Q3 2024 · Sep 30, 2023 −$147.91M
Net Income Q3 2024 · Jun 30, 2023 −$49.79M
Net Income Q3 2024 · Mar 31, 2023 −$46.84M
Operating Income Q3 2024 · Sep 30, 2023 −$46.31M
Operating Income Q3 2024 · Sep 30, 2023 −$137.73M